| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 136.303 | 263.295 | 367.444 | 360.701 | 418.683 | 267.079 | 260.521 | 344.264 | 437.276 | 500.231 |
| Total Income - EUR | 136.305 | 263.296 | 367.445 | 360.702 | 421.018 | 309.630 | 265.259 | 349.718 | 438.856 | 503.959 |
| Total Expenses - EUR | 95.527 | 238.401 | 326.448 | 320.465 | 274.168 | 193.143 | 184.640 | 215.838 | 271.524 | 412.115 |
| Gross Profit/Loss - EUR | 40.778 | 24.896 | 40.997 | 40.236 | 146.849 | 116.488 | 80.619 | 133.880 | 167.331 | 91.844 |
| Net Profit/Loss - EUR | 34.585 | 20.829 | 37.300 | 36.615 | 142.663 | 114.110 | 78.059 | 130.956 | 163.045 | 70.751 |
| Employees | 0 | 43 | 53 | 53 | 45 | 29 | 20 | 18 | 21 | 23 |
Check the financial reports for the company - Medliv Terapia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 832 | 1.910 | 2.142 | 2.102 | 23.546 | 20.231 | 16.360 | 11.943 | 14.730 | 11.633 |
| Current Assets | 55.199 | 56.701 | 96.061 | 94.298 | 272.357 | 372.449 | 126.157 | 142.131 | 202.846 | 124.629 |
| Inventories | 55 | 55 | 0 | 0 | 0 | 0 | 0 | 2.086 | 1.582 | 0 |
| Receivables | 27 | 24.656 | 23.282 | 22.855 | 51.468 | 60.863 | 65.420 | 74.919 | 171.013 | 113.571 |
| Cash | 55.116 | 31.991 | 72.779 | 71.443 | 220.888 | 311.586 | 60.737 | 65.126 | 30.252 | 11.059 |
| Shareholders Funds | 48.331 | 34.435 | 50.676 | 49.746 | 224.864 | 334.711 | 78.099 | 125.233 | 163.085 | 96.897 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.499 | 24.967 | 48.304 | 47.418 | 71.039 | 60.036 | 62.841 | 28.840 | 54.544 | 39.365 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 1.577 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medliv Terapia Srl